Register for our free email digests:
Boston Scientific Corp.
www.bostonscientific.com
Latest From Boston Scientific Corp.
Market Brief: Innovation Will Drive 13% Growth In Global Transcatheter Mitral Valve Repair Market by 2023, Outpacing Growth Of TAVR
The transcatheter heart valve management products market will reach $6.7bn by 2023, driven by the rising prevalence of heart disease. Transcatheter aortic valve replacement (TAVR) procedures lead the market, but innovation and rising competition, including from companies in China and India, will fuel double-digit growth in the much smaller mitral valve repair market, dominated by Abbott's MitraClip.
R&D Roundup, October 2019: TCT Brings More Transcatheter Valve Results, New Product Launches, Reassuring Data On Paclitaxel Risk
An overview of October’s ten most-read Medtech Insight articles on topics related to research and development of new medical technology.
Boston Scientific Q3 Beats Expectations, Emerging Markets Boost Biz
Boston Scientific reported higher than expected Q3 results, with growth across emerging markets boosting company revenue. A number of product launches across the business also helped to drive growth.
Medtronic Expects EV ICD To Reduce ICD Complications, Costs
The pivotal trial of Medtronic’s EV ICD, an implantable cardioverter defibrillator without a transvenous lead, has begun with implants in Illinois and New Zealand. The study will measure device-related complications with the device over six months and test EV ICD's ability to stop ventricular fibrillation.
Company Information
- Industry
-
Medical Devices
- Implantable Devices
- Monitoring Equipment & Devices
- Rehabilitation Equipment and Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
- Therapeutic Areas
- Cancer
- Cardiovascular
- Gynecological, Urological
- Musculoskeletal & Connective Tissue Disorders
- Neurology, Nervous System
- Respiratory, Pulmonary
- Alias(es)
- Cardiovascular Imaging Systems (CVIS)
- Ownership
- Public
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
-
Boston Scientific Corp.
- Advanced Stent Technologies Inc.
- Apama Medical Inc.
- Asthmatx Inc.
- Atritech Inc.
- Augmenix Inc.
- Bard Electrophysiology
- BEI Medical Systems Co. Inc.
- Boston Scientific Japan KK
- BridgePoint Medical Inc.
- BTG PLC
- Cameron Health Inc.
- Cardiac Pathways Corp.
- CardioGene Therapeutics Inc.
- Cardiovascular Imaging Systems Inc.
- Catheter Innovations Inc.
- Claret Medical Inc.
- Corvita Corp.
- CryoCor Inc.
- CryoVascular Systems Inc.
- Embolic Protection Inc.
- EndoChoice Holdings Inc.
- EndoTex Interventional Systems Inc.
- Enteric Medical Technologies Inc.
- EP Technologies Inc.
- Guidant Corp.
- Heart Technology Inc.
- InFlow Dynamics Inc.
- IntElect Medical Inc.
- Interventional Technologies Inc.
- IoGyn Inc.
- Labcoat Ltd.
- Mansfield
- Mansfield EP
- Meadox Medicals Inc.
- Microvasive Inc.
- Millipede Inc.
- MinTec
- nVision Medical Corp.
- Possis Medical Inc.
- Precision Vascular Systems Inc.
- Quanam Medical Corp.
- RadioTherapeutics Corp.
- Remon Medical Technologies Ltd.
- ReVascular Therapeutics Inc.
- Rhythmia Medical Inc.
- Rubicon Medical Corp.
- Sadra Medical Inc.
- Schneider Worldwide
- SciMed Life Systems Inc.
- Securus Medical Group Inc.
- Smart Therapeutics Inc.
- Symbiosis Corp.
- Symetis SA
- Target Therapeutics Inc.
- Veniti Inc.
- VertiFlex Inc.
- Vesica Medical Inc.
- Vessix Vascular Inc.
- XLumena Inc.
- Senior Management
-
Michael F Mahoney, Chmn. & CEO
Daniel J Brennan, EVP, CFO
Ian Meredith, EVP, Global CMO
Edward Mackey, MD, PhD, EVP, Global Operations - Contact Info
-
Boston Scientific Corp.
Phone: (508) 683-4000
300 Boston Scientific Way
Marlborough, MA 01752-1234
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice